Bemdac

  • Zydus Medica
  • Cardiology

BEMDAC is a novel drug exhibiting unique mechanism of action, via inhibition of ATP Citrate Lyase (ACL), an enzyme upstream to HMG CoA reductase in the cholesterol synthesis pathway. This helps bridging an unmet need in the management of patients who are on maximally tolerated statin therapy, yet require additional lowering of LDL-c.

Brand Composition

  • Bempedoic Acid 180mg Tablets
Read More

BEMDAC is a prescription product, please consult your physician for more details.

BEMDAC Usage

Bemdac is indicated as an adjunct to diet and maximally tolerated statins therapy for the treatment of adults with Heterozygous familial hypercholesterolemia (HeFH) or established atherosclerotic cardiovascular disease (ASCVD) who require additional lowering of LDLc.

SEE ALL BRANDS AT ZYDUS HEALTHCARE LIMITED